Puerarin alleviates neuropathic pain by inhibiting neuroinflammation in spinal cord

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Liu, Ming ^a,b,c   Liao, Kaijun ^c   Yu, Changxi ^c   Li, Xuejun ^a   Liu, Suhuan ^a   Yang, Shuyu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; FLUOROCITRIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PUERARIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ISOFLAVONE DERIVATIVE;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CHRONIC CONSTRICTION INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LUMBAR SPINE; MACROGLIA; MALE; MECHANICAL STIMULATION; MECHANICAL STIMULUS TEST; MICROGLIA; MYELITIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; PAIN RECEPTOR; RAT; SHAM PROCEDURE; SPINAL CORD DORSAL HORN; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; UPREGULATION; WESTERN BLOTTING; ANIMAL; COMPLICATION; DRUG EFFECTS; HYPERALGESIA; IMMUNOLOGY; NEURALGIA; SPINAL CORD; SPRAGUE DAWLEY RAT; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANIMALS; CONSTRICTION, PATHOLOGIC; DIABETES MELLITUS, TYPE 1; HYPERALGESIA; ISOFLAVONES; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 84904096814     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/485927     Document Type: Article

References (42)

1. Campbell J. N., Meyer R. A., Mechanisms of neuropathic pain. Neuron 2006 52 1 77 92 10.1016/j.neuron.2006.09.021 2-s2.0-33749061243 (Pubitemid 44466361)
2. Varrassi G., Müller-Schwefe G., Pergolizzi J., Ornska A., Morlion B., Mavrocordatos P., Margarit C., Mangas C., Jaksch W., Huygen F., Collett B., Berti M., Aldington D., Ahlbeck K., Pharmacological treatment of chronic pain the need for CHANGE. Current Medical Research and Opinion 2010 26 5 1231 1245 10.1185/03007991003689175 2-s2.0-77951065733
3. Austin P. J., Moalem-Taylor G., The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. Journal of Neuroimmunology 2010 229 1-2 26 50 10.1016/j.jneuroim. 2010.08.013 2-s2.0-78650309320
4. Vallejo R., Tilley D. M., Vogel L., Benyamin R., The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Practice 2010 10 3 167 184 10.1111/j.1533-2500.2010.00367.x 2-s2.0-77954877647
5. Kawasaki Y., Zhang L., Cheng J. K., Ji R., Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1 β interleukin-6, and tumor necrosis factor- α in regulating synaptic and neuronal activity in the superficial spinal cord. The Journal of Neuroscience 2008 28 20 5189 5194 10.1523/JNEUROSCI.3338-07.2008 2-s2.0-45549090676
6. Watkins L. R., Maier S. F., Glia: a novel drug discovery target for clinical pain. Nature Reviews Drug Discovery 2003 2 12 973 985 10.1038/nrd1251 2-s2.0-0347169249 (Pubitemid 37540579)
7. Zhang Z., Lam T. N., Zuo Z., Radix Puerariae: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2013 53 8 787 811
8. Zheng G., Yu C., Yang Z., Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF- B translocation. International Journal of Oncology 2012 40 5 1610 1618 10.3892/ijo.2012.1331 2-s2.0-84860310820
9. Singh A. K., Jiang Y., Gupta S., Younus M., Ramzan M., Anti-inflammatory potency of nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-induced inflammation. Journal of Medicinal Food 2013 16 10 899 911 10.1089/jmf.2012.0049
10. Liu Y., Shao L. L., Pang W., Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor kappa B pathways. Chinese Journal of Integrative Medicine 2014 20 5 360 368
11. LoPachin R. M., Rudy T. A., Yaksh T. L., An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiology and Behavior 1981 27 3 559 561 10.1016/0031-9384(81)90350-4 2-s2.0-0019842524 (Pubitemid 12239238)
12. 1 receptor in early diabetic pain neuropathy. Journal of Neuroinflammation 2010 7, article 36 10.1186/1742-2094-7-36 2-s2.0-77953951240
13. Bennett G. J., Xie Y. K., A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988 33 1 87 107 10.1016/0304-3959(88)90209-6 2-s2.0-0023895875
14. Mitrirattanakul S., Ramakul N., Guerrero A. V., Matsuka Y., Ono T., Iwase H., Mackie K., Faull K. F., Spigelman I., Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain 2006 126 1-3 102 114 10.1016/j.pain.2006.06.016 2-s2.0-33751244807 (Pubitemid 44781351)
15. Tchivileva I. E., Nackley A. G., Qian L., Wentworth S., Conrad M., Diatchenko L. B., Characterization of NF- B-mediated inhibition of catechol- O -methyltransferase. Molecular Pain 2009 5, article 13 10.1186/1744-8069-5-13 2-s2.0-64049091501
16. Cheng J., Chou R. C., Hwang L., Chiou L., Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. Journal of Pharmacology and Experimental Therapeutics 2003 307 3 1065 1071 10.1124/jpet.103.056663 2-s2.0-0344304799 (Pubitemid 37494226)
17. DeLeo J. A., Yezierski R. P., The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001 90 1-2 1 6 10.1016/S0304-3959(00)00490-5 2-s2.0-0035252354 (Pubitemid 32146552)
18. Hashizume H., DeLeo J. A., Colburn R. W., Weinstein J. N., Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 2000 25 10 1206 1217 10.1097/00007632-200005150-00003 2-s2.0-0034657820 (Pubitemid 30322310)
19. Okamoto K., Martin D. P., Schmelzer J. D., Mitsui Y., Low P. A., Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Experimental Neurology 2001 169 2 386 391 10.1006/exnr.2001.7677 2-s2.0-0034994231 (Pubitemid 32524432)
20. Moalem G., Tracey D. J., Immune and inflammatory mechanisms in neuropathic pain. Brain Research Reviews 2006 51 2 240 264 10.1016/j. brainresrev.2005.11.004 2-s2.0-33745153343 (Pubitemid 43902971)
21. Makarov S. S., NF- b as a therapeutic target in chronic inflammation: recent advances. Molecular Medicine Today 2000 6 11 441 448 10.1016/S1357- 4310(00)01814-1 2-s2.0-0033623536
22. Marchand F., Perretti M., McMahon S. B., Role of the immune system in chronic pain. Nature Reviews Neuroscience 2005 6 7 521 532 10.1038/nrn1700 2-s2.0-21744433587 (Pubitemid 40942819)
23. Sakaue G., Shimaoka M., Fukuoka T., Hiroi T., Inoue T., Hashimoto N., Sakaguchi T., Sawa Y., Morishita R., Kiyono H., Noguchi K., Mashimo T., NF- B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. NeuroReport 2001 12 10 2079 2084 10.1097/00001756- 200107200-00008 2-s2.0-0035919810 (Pubitemid 32646249)
24. Hanada T., Yoshimura A., Regulation of cytokine signaling and inflammation. Cytokine and Growth Factor Reviews 2002 13 4-5 413 421 10.1016/S1359-6101(02)00026-6 2-s2.0-0036694663
25. Li H., Lin X., Positive and negative signaling components involved in TNF α -induced NF- B activation. Cytokine 2008 41 1 1 8 10.1016/j.cyto.2007. 09.016 2-s2.0-37449033866 (Pubitemid 50012147)
26. Ma W., Bisby M. A., Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Research 1998 797 2 243 254 10.1016/S0006-8993(98)00380-1 2-s2.0-0032578025 (Pubitemid 28332737)
27. Milligan E. D., Watkins L. R., Pathological and protective roles of glia in chronic pain. Nature Reviews Neuroscience 2009 10 1 23 36 10.1038/nrn2533 2-s2.0-57749200564
28. Old E. A., Malcangio M., Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states. Current Opinion in Pharmacology 2012 12 1 67 73 10.1016/j.coph.2011.10.015 2-s2.0-84857233639
29. Suter M. R., Wen Y. R., Decosterd I., Ji R., Do glial cells control pain? Neuron Glia Biology 2007 3 3 255 268 10.1017/S1740925X08000100 2-s2.0-42649097577 (Pubitemid 351594231)
30. Attal N., Bouhassira D., Neuropathic pain: experimental advances and clinical applications. Revue Neurologique 2004 160 2 199 203 10.1016/S0035-3787(04)70891-7 2-s2.0-1542374158 (Pubitemid 38325737)
31. Calcutt N. A., Potential mechanisms of neuropathic pain in diabetes. International Review of Neurobiology 2002 50 205 228 10.1016/S0074-7742(02) 50078-7 2-s2.0-0036369155
32. Simmons Z., Feldman E. L., Update on diabetic neuropathy. Current Opinion in Neurology 2002 15 5 595 603 10.1097/00019052-200210000-00010 2-s2.0-0036797742 (Pubitemid 35176694)
33. Hassel B., Paulsen R. E., Johnsen A., Fonnum F., Selective inhibition of glial cell metabolism in vivo by fluorocitrate. Brain Research 1992 576 1 120 124 10.1016/0006-8993(92)90616-H 2-s2.0-0026603607
34. Paulsen R. E., Contestabile A., Villani L., Fonnum F., An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate. Journal of Neurochemistry 1987 48 5 1377 1385 10.1111/j.1471-4159.1987.tb05674.x 2-s2.0-0023226069 (Pubitemid 17068716)
35. Milligan E. D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., Tracey K., Martin D., Maier S. F., Watkins L. R., Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. The Journal of Neuroscience 2003 23 3 1026 1040 2-s2.0-0037320840 (Pubitemid 36206195)
36. Nakagawa T., Wakamatsu K., Zhang N., Maeda S., Minami M., Satoh M., Kaneko S., Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance. Neuroscience 2007 147 2 445 455 10.1016/j.neuroscience.2007.03.045 2-s2.0-34250217010 (Pubitemid 46907446)
37. Obata H., Eisenach J. C., Hussain H., Bynum T., Vincler M., Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. The Journal of Pain 2006 7 11 816 822 10.1016/j.jpain.2006.04.004 2-s2.0-33750367331 (Pubitemid 44636363)
38. Mika J., Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Pharmacological Reports 2008 60 3 297 307 2-s2.0-49349110301
39. Zhang Y. P., Song C. Y., Yuan Y., Eber A., Rodriguez Y., Levitt R. C., Takacs P., Yang Z., Goldberg R., Candiotti K. A., Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10. Neurobiology of Disease 2013 58 169 178 10.1016/j.nbd.2013.05.003 2-s2.0-84879476551
40. Chen Y. W., Hsieh P. L., Hung Y. C., Cheng J. T., Physical exercise induces excess hsp72 expression and delays the development of hyperalgesia and allodynia in painful diabetic neuropathy rats. Anesthesia and Analgesia 2013 116 2 482 490 10.1213/ANE.0b013e318274e4a0 2-s2.0-84872857816
41. Ren P., Zhang Y., Zhang X., An L., Lv H., He J., Gao C., Sun X., High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes. Brain Research Bulletin 2012 88 4 332 337 10.1016/j.brainresbull.2012.03.002 2-s2.0-84862220100
42. Wen Y. R., Tan P. H., Cheng J. K., Liu Y., Ji R., Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. Journal of the Formosan Medical Association 2011 110 8 487 494 10.1016/S0929-6646(11)60074-0 2-s2.0-79960807502